Back to results
US 8,575,360 B2Granted
Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amides
AssigneeBoehringer Ingelheim International GmbH
InventorsRene Marc Lemieux, Steven Richard Brunette, Joshua Courtney Horan, Jennifer A. Kowalski, Michael David Lawlor, Bryan McKibben, Craig Andrew Miller, Antonio J. M. Barbosa
Life of this patent
Estimating the term…
Abstract
Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amide exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.
Claims34
A compound of formula I:
- wherein:
- R1 is selected from —CN, —OCF3, —CF3, halogen, heteroaryl optionally substituted with halogen or C1-3 alkyl and phenyl optionally substituted with halogen;
- R2 is —Cl or —CF3;
- R3 is H or halogen;
- X is a group
- wherein
- R4 is selected from:
- (A)-H;
- (B) C1-3 alkyl optionally substituted with one or two groups selected from:
- a) C3-6cycloalkyl;
- b) —OR9;
- c) —NR9R10;
- d) —SOR9;
- e) —SO2R9;
- f) —C(O)NR9R10;
- g) —C(O)OR9;
- h) heteroaryl, optionally substituted with C1-3 alkyl;
- i) heterocycyl, optionally substituted with C1-3 alkyl;
- and
- j) phenyl optionally substituted with C1-3 alkyl;
- (C) C3-6cycloalkyl;
- (D)heteroaryl;
- and
- (E) phenyl, optionally substituted with halogen, —OR9, —CN or —CF3;
- R5 is H or C1-3alkyl;
- or
- R4 and R5, together with the carbon they are bonded to, form a saturated hydrocarbon ring with 3-7 carbon atoms and wherein one carbon atom in said hydrocarbon ring may be optionally replaced by —O—, —S—, —S(O)—, —SO2—, —NH—, —NCH3—, or —NC(O)CH3—;
- Y is a group
- wherein
- R6 is H or C1-3alkyl;
- R7 is H or C1-3alkyl;
- or
- R6 and R7, together with the carbon they are bonded to, form a saturated hydrocarbon ring with 3-7 carbon atoms wherein one carbon atom in said hydrocarbon ring may be optionally replaced by —O—, —S—, —S(O) —, —SO2—, —NH—, —NCH3—, or —NC(O)CH3—;
- Z is aryl or heteroaryl;
- R8 is selected from:
- (A) aryl optionally substituted with one or two groups selected from:
- (a) C1-3alkyl optionally substituted with —OR9, —NR9R10 or —NR9SO2R10;
- (b) C3-7cycloalkyl optionally substituted with —OR9 or —NR9R10;
- (a) —OR9;
- (c) halogen;
- (d) —C(O)NR9R10;
- (e) —SO2NR9R10;
- (f) —NR9(CO)R10;
- (g) —SO2R9;
- (h) —NR9R10;
- (i) —CN;
- (j) —C(O)OR9;
- (k) —NR9SO2R10;
- and
- (l) —C(O)R9;
- and
- (B) heteroaryl optionally substituted with one to two groups selected from:
- (a) C1-3alkyl optionally substituted with —OR9, NR9R10 or halogen;
- (b) C3-7cycloalkyl optionally substituted with —OR9, NR9R10;
- (a) —OR9;
- (c) halogen;
- (d) —C(O)NR9R10;
- (e) —SO2NR9R10;
- (f) —NR9(CO)R10;
- (g) —SO2R9;
- (h) —NR9R10;
- and
- (i) —CN;
- R9 is selected from H, C1-5alkyl or C3-7cycloalkyl;
- R10 is selected from H, C1-5alkyl or C3-7cycloalkyl;
- or a pharmaceutically acceptable salt thereof.
63 more elements
A compound selected from the compounds in the following Table 1:
- TABLE 1
- Compound
- R1
- R2
- R3
- X
- Y
- Z
- R8
- 1
- CN
- Cl
- F
- 2
- CN
- Cl
- F
- 3
- CN
- Cl
- F
- 4
- OCF3
- Cl
- F
- 5
- CN
- Cl
- F
- 6
- CN
- Cl
- F
- 7
- OCF3
- Cl
- F
- 8
- OCF3
- Cl
- F
- 9
- CN
- Cl
- H
- 10
- CN
- Cl
- F
- 11
- CN
- Cl
- F
- 12
- OCF3
- Cl
- F
- 13
- CN
- Cl
- F
- 14
- CN
- Cl
- F
- 15
- CN
- Cl
- F
- 16
- CN
- Cl
- F
- 17
- OCF3
- Cl
- F
- 18
- CN
- Cl
- F
- 19
- CN
- Cl
- F
- 20
- OCF3
- Cl
- F
- 21
- CN
- Cl
- F
- 22
- CN
- Cl
- H
- 23
- CN
- Cl
- F
- 24
- OCF3
- Cl
- H
- 25
- CN
- Cl
- F
- 26
- CF3
- Cl
- H
- 27
- CN
- Cl
- F
- 28
- OCF3
- Cl
- F
- 29
- CN
- Cl
- F
- 30
- CN
- Cl
- F
- 31
- CN
- Cl
- F
- 32
- CN
- Cl
- F
- 33
- CN
- Cl
- F
- 34
- CN
- Cl
- F
- 35
- CN
- Cl
- F
- 36
- CN
- Cl
- F
- 37
- CN
- Cl
- F
- 38
- CN
- Cl
- F
- 39
- OCF3
- Cl
- F
- 40
- OCF3
- Cl
- F
- 41
- OCF3
- Cl
- F
- +
- 42
- OCF3
- Cl
- F
- 43
- CN
- Cl
- F
- 44
- CN
- Cl
- F
- 45
- CN
- Cl
- F
- 46
- OCF3
- Cl
- F
- 47
- OCF3
- Cl
- F
- 48
- OCF3
- Cl
- F
- 49
- OCF3
- Cl
- F
- 50
- CN
- Cl
- F
- 51
- CN
- CF3
- H
- 52
- CN
- Cl
- H
- 53
- CN
- Cl
- H
- 54
- CN
- Cl
- H
- 55
- CN
- Cl
- H
- 56
- CN
- Cl
- H
- 57
- CN
- Cl
- H
- 58
- CN
- Cl
- H
- 59
- CN
- Cl
- H
- 60
- CN
- Cl
- H
- 61
- CN
- Cl
- H
- 62
- CN
- Cl
- H
- 63
- CN
- Cl
- H
- 64
- CN
- Cl
- F
- 65
- CN
- Cl
- F
- 66
- CN
- Cl
- H
- 67
- CN
- Cl
- H
- 68
- CN
- Cl
- F
- 69
- CN
- Cl
- F
- 70
- CN
- Cl
- F
- 71
- CN
- Cl
- H
- 72
- CN
- Cl
- F
- 73
- CN
- Cl
- F
- 74
- CN
- Cl
- F
- 75
- Br
- Cl
- H
- 76
- Cl
- Cl
- H
- 77
- CN
- Cl
- F
- 78
- CN
- Cl
- F
- 79
- CN
- Cl
- H
- 80
- CN
- Cl
- H
- 81
- CN
- Cl
- H
- 82
- CN
- Cl
- H
- 83
- CN
- Cl
- H
- 84
- CN
- Cl
- H
- 85
- CN
- Cl
- F
- 86
- OCF3
- Cl
- F
- 87
- CN
- Cl
- F
- 88
- CN
- Cl
- F
- 89
- OCF3
- Cl
- F
- 90
- CN
- Cl
- F
- 91
- CN
- Cl
- H
- 92
- CN
- Cl
- H
- 93
- CN
- Cl
- F
- 94
- CN
- Cl
- F
- 95
- CN
- Cl
- F
- 96
- CN
- Cl
- F
- 97
- OCF3
- Cl
- H
- 98
- CN
- Cl
- H
- 99
- OCF3
- Cl
- F
- 100
- CN
- Cl
- F
- 101
- CN
- Cl
- F
- 102
- CN
- Cl
- F
- 103
- OCF3
- Cl
- H
- 104
- OCF3
- Cl
- F
- 105
- CN
- Cl
- F
- 106
- CN
- Cl
- F
- 107
- CN
- Cl
- F
- 108
- OCF3
- Cl
- F
- 109
- CN
- Cl
- F
- 110
- OCF3
- Cl
- F
- 111
- CN
- Cl
- F
- 112
- CN
- Cl
- F
- 113
- CN
- Cl
- F
- 114
- CN
- Cl
- F
- 115
- CN
- Cl
- F
- 116
- OCF3
- Cl
- F
- 117
- CN
- Cl
- F
- 118
- OCF3
- Cl
- F
- 119
- CN
- Cl
- F
- 120
- OCF3
- Cl
- F
- 121
- CN
- Cl
- F
- 122
- CN
- Cl
- F
- 123
- CN
- Cl
- F
- 124
- CN
- Cl
- H
- 125
- OCF3
- Cl
- F
- 126
- CN
- Cl
- H
- 127
- CN
- Cl
- H
- 128
- CN
- Cl
- H
- 129
- CN
- Cl
- H
- 130
- CN
- Cl
- H
- 131
- CN
- Cl
- H
- 132
- CN
- Cl
- H
- 133
- CN
- Cl
- H
- 134
- CN
- Cl
- H
- 135
- CN
- Cl
- H
- 136
- CN
- Cl
- H
- 137
- CN
- Cl
- H
- 138
- CN
- Cl
- H
- 139
- CN
- Cl
- H
- 140
- CN
- Cl
- H
- 141
- CN
- Cl
- H
- 142
- CN
- Cl
- H
- 143
- CN
- Cl
- H
- 144
- CN
- Cl
- H
- 145
- CN
- Cl
- F
- 146
- CN
- Cl
- H
- 147
- CN
- Cl
- H
- 148
- CN
- Cl
- H
- 149
- CN
- Cl
- H
- 150
- OCF3
- Cl
- F
- 151
- CN
- Cl
- F
- 152
- CN
- Cl
- F
- 153
- OCF3
- Cl
- F
- 154
- CN
- Cl
- F
- 155
- CN
- Cl
- F
- 156
- CN
- Cl
- F
- 157
- CN
- Cl
- F
- 158
- CN
- Cl
- F
- 159
- CN
- Cl
- F
- and
- 160
- CN
- Cl
- F
- or a pharmaceutically acceptable salt thereof.
649 more elements
Dependencies are inferred from the claim text.